Date: Thursday 26 Apr 2012
LONDON (ShareCast) - Admiral: Oriel Securities retains sell rating and 740p target.
AstraZeneca: Panmure Gordon maintains buy rating and 3,600p target.
Barclays: Nomura reiterates neutral rating and 268p target; Exane BNP Paribas keeps outperform rating and 300p target; Oriel Securities keeps buy rating and 285p target; Seymour Pierce keeps hold rating and 200p target; Investec keeps buy rating and 240p target.
Berendsen: Seymour Pierce downgrades from buy to add, 545p target kept.
Capita: UBS cuts target from 725p to 700p, neutral rating kept.
Dixon Retail: AlphaValue downgrades to from buy to add, raises target to €21.30 from €21.20.
Howden Joinery: Espirito Santo reiterates buy recommendation and 150p target.
HSBC: Exane BNP Paribas keeps outperform rating and 675p target.
GlaxoSmithKline: Panmure Gordon reiterates hold rating and 1,450pt argot.
Go-Ahead Group: Panmure Gordon cuts target from 1,450p to 1,250p, hold recommendation kept.
Ladbrokes: Nomura raises target from 135p to 150p, neutral rating unchanged.
Lloyds: Exane BNP Paribas keeps outperform rating and and 45p target.
UBM: Nomura ups target from 665p to 675p, buy rating kept.
Unilever: Panmure Gordon reiterates buy rating and 2,300p target.
Whitbread: Panmure Gordon maintains hold rating and 1,768p target; Shore Capital maintains buy rating.
William Hill: Nomura lifts target from 190p to 205p, reduce rating unchanged.
or share it with one of these popular networks:
|% Change||0.92 %|
|52 Week High||332.00|
|52 Week Low||167.90|
|Time||Volume / Share Price|
|16:35||98,138 @ 328.00p|
|16:29||600 @ 327.20p|
|16:29||700 @ 327.60p|
|16:29||257 @ 327.60p|
|16:29||600 @ 327.60p|
You are here: research